Correction: The role of Seladelpar in primary biliary cholangitis: a systematic review and meta-analysis

Documenti analoghi

• Mechanistic Rationale of Seladelpar’s Clinical Efficacy through the Selective PPAR-δ Activation in Primary Biliary Cholangitis
  di: Alessio Gerussi, et al.
  Pubblicazione: (2026-03-01)
• Correction: The role of Seladelpar in primary biliary cholangitis: a systematic review and meta-analysis
  di: Taimoor Ashraf, et al.
  Pubblicazione: (2025-08-01)
• Second-Line Therapies in Primary Biliary Cholangitis: A Comparative Review of Obeticholic Acid, Fibrates, Seladelpar, and Elafibranor
  di: Fares Jamal, et al.
  Pubblicazione: (2025-09-01)
• The Efficacy and Safety of Seladelpar for Primary Biliary Cholangitis: A Systematic Review and Meta‐Analysis
  di: Mohamed Abuelazm, et al.
  Pubblicazione: (2025-09-01)
• Evolving paradigms in primary biliary cholangitis: from molecular mechanisms to personalized therapeutics with seladelpar, elafibranor, and beyond
  di: Bushra Qasim, et al.
  Pubblicazione: (2025-10-01)